Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China

Yuan Xu; Ying Wang; Runhui Wu; Changcheng Zheng; Li Zhang; Weiqun Xu; Xiaoqin Feng; Hua Wang; Xiang-shan Cao; Liya He; Tianyang Xue; Mingwei Jin; Bingshou Xie; Jing Ling; Lirong Sun; Rui Su; Hongbo Cheng; Yongjun Fang; Man‐Chiu Poon; Wei Liu; Lei Zhang; Feng Xue; Renchi Yang

doi:10.1111/hae.15062

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Reduced doses of emicizumab improve the affordability among patients in developing countries. However, the relationship between variant dose selection and efficacy in the real world of China is still unclear.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xu et al. (2024) studied this question.

synapsesocial.com/papers/68e6585fb6db6435875e708b https://doi.org/10.1111/hae.15062

View at Publisher

Ask AI

Bookmark

Share

Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China

Ask about this paper

Abstract

Discussion

Cite This Study

Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading